Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Bluejay Diagnostics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2023 |
8-K
| Quarterly results |
| 05/10/2023 |
8-K
| Quarterly results |
| 03/20/2023 |
8-K
| Quarterly results |
| 11/08/2022 |
8-K
| Quarterly results|
Docs:
|
"Bluejay Diagnostics, Inc. Reports Third Quarter 2022 Financial Results Acton, Massachusetts, October 25, 2022 – Bluejay Diagnostics, Inc. , a clinical-stage medical diagnostics company developing rapid, near-patient tests using whole blood on its Symphony platform to improve patient outcomes in critical care settings, today reported its financial results for the quarter and nine months ended September 30, 2022. “The last quarter focused on increasing awareness of Bluejay’ s Symphony IL-6 test by directly engaging the medical community to build a network of champions that will direct product development and drive initial commercialization,” said Neil Dey, CEO. “In August, Bluejay held a KOL event with clinicians in emergency and critical care who shared their perspectives on Symphony’ s pot..." |
|
| 07/26/2022 |
8-K
| Quarterly results |
| 04/20/2022 |
8-K
| Quarterly results |
| 03/10/2022 |
8-K
| Quarterly results |
| 12/16/2021 |
8-K
| Quarterly results |
|
|